Pharm-Olam to Exhibit at Partnerships in Clinical Trials in Vienna
HOUSTON, TEXAS Nov 4, 2010. Pharm-Olam International Ltd. (POI), a multi-national, full service CRO to pharmaceutical and biotech industries announced today that it will be exhibiting at the annual Partnerships in Clinical Trials conference in Vienna, Austria on November 16-19, 2010.
Pharm-Olam attendees will include Dr. Zev Munk, CEO and founder of POI since 1994. Dr. Munk is a specialist in Allergy and Immunology with over 20 years of experience as a principle investigator in over 200 clinical trials.
Pharm-Olam looks forward to sharing our significant experience in clinical trials at the Partnerships conference exhibition hall at booth #239.
Attendees are encouraged to stop by to visit with our representatives and learn more about Pharm-Olam’s capabilities and experience. Contact John Hovre at firstname.lastname@example.org to arrange specific meeting time.
About Pharm-Olam International Group
Pharm-Olam International is a multi-national contract research organization offering a wide range of comprehensive, clinical research services to the pharmaceutical, biotechnology and medical device industries. From Phase I to Phase IV, POI focuses on delivering the highest quality data, achieving targeted enrollment and meeting projected timelines.